Biotech Committee

 View Only
last person joined: one year ago 

The SITC Biotech Committee is working to design a robust and sustainable ecosystem for the Immuno-Oncology (IO) Biotech Community. The committee aims to harness the collective entrepreneurial spirit, intellectual power, and commitment of leaders in the biotech industry, financial, pharmaceutical, government, and academic sectors to accelerate the development of new IO agents to cure and prevent cancer.

Chair
Zhen Su, MD, MBA
Marengo Therapeutics


Co-Chair
Kristen M. Hege, MD
Bristol Myers Squibb (previously employed)

Most Active